Cargando…
Smart Polymeric Nanoparticles in Cancer Immunotherapy
Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery ca...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056399/ https://www.ncbi.nlm.nih.gov/pubmed/36986636 http://dx.doi.org/10.3390/pharmaceutics15030775 |
_version_ | 1785016112242491392 |
---|---|
author | Yu, Zhecheng Shen, Xingyue Yu, Han Tu, Haohong Chittasupho, Chuda Zhao, Yunqi |
author_facet | Yu, Zhecheng Shen, Xingyue Yu, Han Tu, Haohong Chittasupho, Chuda Zhao, Yunqi |
author_sort | Yu, Zhecheng |
collection | PubMed |
description | Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery carriers for targeted cancer therapy. Polymeric nanoparticles used in the clinic are biocompatible and have excellent stability. They have the potential to improve therapeutic effects while significantly reducing off-target toxicity. This review classifies smart drug delivery systems based on their components. Synthetic smart polymers used in the pharmaceutical industry, including enzyme-responsive, pH-responsive, and redox-responsive polymers, are discussed. Natural polymers derived from plants, animals, microbes, and marine organisms can also be used to construct stimuli-responsive delivery systems with excellent biocompatibility, low toxicity, and biodegradability. The applications of smart or stimuli-responsive polymers in cancer immunotherapies are discussed in this systemic review. We summarize different delivery strategies and mechanisms that can be used in cancer immunotherapy and give examples of each case. |
format | Online Article Text |
id | pubmed-10056399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100563992023-03-30 Smart Polymeric Nanoparticles in Cancer Immunotherapy Yu, Zhecheng Shen, Xingyue Yu, Han Tu, Haohong Chittasupho, Chuda Zhao, Yunqi Pharmaceutics Review Cancer develops with unexpected mutations and causes death in many patients. Among the different cancer treatment strategies, immunotherapy is promising with the benefits of high specificity and accuracy, as well as modulating immune responses. Nanomaterials can be used to formulate drug delivery carriers for targeted cancer therapy. Polymeric nanoparticles used in the clinic are biocompatible and have excellent stability. They have the potential to improve therapeutic effects while significantly reducing off-target toxicity. This review classifies smart drug delivery systems based on their components. Synthetic smart polymers used in the pharmaceutical industry, including enzyme-responsive, pH-responsive, and redox-responsive polymers, are discussed. Natural polymers derived from plants, animals, microbes, and marine organisms can also be used to construct stimuli-responsive delivery systems with excellent biocompatibility, low toxicity, and biodegradability. The applications of smart or stimuli-responsive polymers in cancer immunotherapies are discussed in this systemic review. We summarize different delivery strategies and mechanisms that can be used in cancer immunotherapy and give examples of each case. MDPI 2023-02-26 /pmc/articles/PMC10056399/ /pubmed/36986636 http://dx.doi.org/10.3390/pharmaceutics15030775 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yu, Zhecheng Shen, Xingyue Yu, Han Tu, Haohong Chittasupho, Chuda Zhao, Yunqi Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title | Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title_full | Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title_fullStr | Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title_full_unstemmed | Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title_short | Smart Polymeric Nanoparticles in Cancer Immunotherapy |
title_sort | smart polymeric nanoparticles in cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056399/ https://www.ncbi.nlm.nih.gov/pubmed/36986636 http://dx.doi.org/10.3390/pharmaceutics15030775 |
work_keys_str_mv | AT yuzhecheng smartpolymericnanoparticlesincancerimmunotherapy AT shenxingyue smartpolymericnanoparticlesincancerimmunotherapy AT yuhan smartpolymericnanoparticlesincancerimmunotherapy AT tuhaohong smartpolymericnanoparticlesincancerimmunotherapy AT chittasuphochuda smartpolymericnanoparticlesincancerimmunotherapy AT zhaoyunqi smartpolymericnanoparticlesincancerimmunotherapy |